LexDanaLexDanabeta
Inventor

Samuel WEISBROD

Inventor
DE

Overview

4→
Patents
2022–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 4 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes44%
C07KPeptides33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations22%
PatentTitleYear
12,246,070Hydrogel cross-linked hyaluronic acid prodrug compositions and methods202511,896,671Conjugation method for carrier-linked prodrugs202411,642,415Hydrogel cross-linked hyaluronic acid prodrug compositions and methods202311,298,427Prodrugs comprising a pyroglutamate linker2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2025Patents assigned to ASCENDIS PHARMA AS (4)· patent assignee history
2022Patents assigned to ASCENDIS PHARMA INC (1)· patent assignee history
2022–2025Based in DE· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
ASCENDIS PHARMA AS42022–2025
ASCENDIS PHARMA INC12022
Locations
LocationPatentsSpan
DE42022–2025